Colorectal cancer (CRC) cells expressing the wild-type p53 gene are resistant against erastin-induced ferroptosis, whereas dipeptidyl peptidase-4 (DPP4), a lipid metabolism regulator also known as CD26, is responsible for this resistance [86]. Here, TP53 is linked to colorectal carcinoma.